Article Versions Notes

Saravi B, Li Z, Pfannkuche J, Wystrach L, Häckel S, E. Albers C, Grad S, Alini M, Richards RG, Lang C, et al. Angiotensin II Type 1 Receptor Antagonist Losartan Inhibits TNF-α-Induced Inflammation and Degeneration Processes in Human Nucleus Pulposus Cells. Applied Sciences. 2021; 11(1):417. https://doi.org/10.3390/app11010417

Saravi, Babak, Zhen Li, Judith Pfannkuche, Laura Wystrach, Sonja Häckel, Christoph E. Albers, Sibylle Grad, Mauro Alini, Robert Geoffrey Richards, Corinna Lang, and et al. 2021. "Angiotensin II Type 1 Receptor Antagonist Losartan Inhibits TNF-α-Induced Inflammation and Degeneration Processes in Human Nucleus Pulposus Cells" Applied Sciences 11, no. 1: 417. https://doi.org/10.3390/app11010417

Saravi, B., Li, Z., Pfannkuche, J., Wystrach, L., Häckel, S., E. Albers, C., Grad, S., Alini, M., Richards, R. G., Lang, C., Südkamp, N., Schmal, H., & Lang, G. (2021). Angiotensin II Type 1 Receptor Antagonist Losartan Inhibits TNF-α-Induced Inflammation and Degeneration Processes in Human Nucleus Pulposus Cells. Applied Sciences, 11(1), 417. https://doi.org/10.3390/app11010417